AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Fabrinet, you need to believe its role in high speed optical and AI infrastructure can support durable growth despite customer concentration and supply chain pressures. The upcoming June 2026 earnings are a key short term catalyst for sentiment, but the latest Earnings ESP and Zacks Rank mix do not materially change the core near term risk around dependence on a few large customers.
The most relevant recent development here is Fabrinet’s updated Q4 FY2026 guidance, calling for US$1.25 billion to US$1.29 billion in revenue and US$3.48 to US$3.63 in GAAP diluted EPS. This guidance frames expectations around the same demand trends that could amplify customer concentration risk if orders from NVIDIA or Cisco were to slow meaningfully.
Yet beneath the optimism around AI optics, investors should still be aware of how exposed Fabrinet is if a single major customer were to...
Read the full narrative on Fabrinet (it's free!)
Fabrinet's narrative projects $8.0 billion revenue and $845.5 million earnings by 2029. This requires 23.8% yearly revenue growth and roughly a doubling of earnings from $421.0 million today.
Uncover how Fabrinet's forecasts yield a $732.44 fair value, a 39% upside to its current price.
The lowest estimate analysts paint a much more cautious picture than consensus, even as they still model revenue reaching about US$7.5 billion and earnings of roughly US$827 million by 2029, reminding you that views on Fabrinet’s upside and its customer and cost risks can differ widely and may shift again after this latest earnings news.
Explore 8 other fair value estimates on Fabrinet - why the stock might be worth as much as 61% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com